Literature DB >> 18086664

Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin.

Alistair Boath1, Christine Graf, Emilie Lidome, Thomas Ullrich, Peter Nussbaumer, Frédéric Bornancin.   

Abstract

Ceramide 1-phosphate (C1P) has been characterized as a sphingolipid that participates in cell signaling. Although C1P synthesis is thought to occur via phosphorylation of ceramide by ceramide kinase (CerK), the processes that regulate C1P formation and fate remain largely unknown. In this study we analyzed bone marrow-derived macrophages (BMDM) from CerK-null mice (Cerk(-/-)) and found significant levels of C1P, suggesting that previously unrecognized pathways may also lead to C1P formation. After these experiments we used an overexpression system, BMDM from Cerk(-/-) mice, and short-chain fluorescent ceramides to trace CerK-dependent formation of C1P. Because the ceramide analogs can also be converted to glucosylceramide (GlcCer) and sphingomyelin (SM), they allowed us to directly compare all three metabolites. We found that C1P produced by CerK is turned over rapidly when serum is removed or upon calcium chelation, whereas GlcCer and SM are stable under these conditions. We further demonstrated that ceramide must be transported to the Golgi complex to be phosphorylated by CerK. Inhibition of the ceramide transfer protein slowed down SM formation without decreasing C1P, suggesting an alternate route of ceramide transport. Other experiments indicated that, like GlcCer and SM, C1P traffics along the secretory pathway to reach the plasma membrane. Furthermore, in BMDM C1P was secreted more readily than was GlcCer or SM. Altogether, our results indicate that CerK is essential to C1P formation via phosphorylation of Cer, providing the first insights into mechanisms underlying ceramide access to CerK and C1P trafficking as well as clarifying C1P as a signaling entity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086664     DOI: 10.1074/jbc.M707107200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Lateral Segregation of Palmitoyl Ceramide-1-Phosphate in Simple and Complex Bilayers.

Authors:  Md Abdullah Al Sazzad; Tomokazu Yasuda; Thomas K M Nyholm; J Peter Slotte
Journal:  Biophys J       Date:  2019-05-21       Impact factor: 4.033

Review 2.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Authors:  M Z Ratajczak; C H Kim; A Abdel-Latif; G Schneider; M Kucia; A J Morris; M J Laughlin; J Ratajczak
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

3.  Synthesis and characterization of BODIPY-alpha-tocopherol: a fluorescent form of vitamin E.

Authors:  Ryan West; Candace Panagabko; Jeffrey Atkinson
Journal:  J Org Chem       Date:  2010-05-07       Impact factor: 4.354

Review 4.  Ceramide-1-phosphate in phagocytosis and calcium homeostasis.

Authors:  Vania Hinkovska-Galcheva; James A Shayman
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 5.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death.

Authors:  Oleksandr Pastukhov; Stephanie Schwalm; Uwe Zangemeister-Wittke; Doriano Fabbro; Frederic Bornancin; Lukasz Japtok; Burkhard Kleuser; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 7.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

8.  Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis.

Authors:  Nadia F Lamour; Preeti Subramanian; Dayanjan S Wijesinghe; Robert V Stahelin; Joseph V Bonventre; Charles E Chalfant
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

9.  Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels.

Authors:  Dayanjan S Wijesinghe; Jeremy C Allegood; Luciana B Gentile; Todd E Fox; Mark Kester; Charles E Chalfant
Journal:  J Lipid Res       Date:  2009-08-04       Impact factor: 5.922

10.  Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice.

Authors:  Satoru Niwa; Nicole Urtz; Thomas Baumruker; Andreas Billich; Frédéric Bornancin
Journal:  Lipids Health Dis       Date:  2010-01-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.